UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Challenges in Management of Immune Checkpoint Inhibitor-Associated Hepatitis

EMJ. Gastroenterology, 2023-10

Cunningham, Morven

2023

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all?

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (7), p.905-906

Cunningham, Morven

2024

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

PloS one, 2021-06, Vol.16 (6), p.e0253070

2021

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension

Canadian journal of gastroenterology & hepatology, 2019-01, Vol.2019, p.1808797-7

2019

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a “capture‐fusion” model to study drug sensitivity of patient‐derived hepatitis C

Hepatology (Baltimore, Md.), 2015-04, Vol.61 (4), p.1192-1204

2015

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint inhibitor hepatotoxicity: pathogenesis and management

Hepatology (Baltimore, Md.), 2024-01, Vol.79 (1), p.198-212

2024

Link zum Volltext

Verfügbarkeit prüfen

Second generation direct antivirals and the way to interferon-free regimens in chronic HCV

Baillière's best practice & research. Clinical gastroenterology, 2012-08, Vol.26 (4), p.471-485

2012

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity

Pulmonary circulation, 2012-10, Vol.2 (4), p.501-504

2012

Link zum Volltext

Verfügbarkeit prüfen

Primary care nursing and liver management: a qualitative study from a telemedicine education program

Annals of family medicine, 2023-01, Vol.21 (S1)

2023

Link zum Volltext

Verfügbarkeit prüfen

North American evaluation of 2519 patients with primary sclerosing cholangitis: longitudinal patterns of disease activity identify and validate stable and progressive phenotypes

Journal of hepatology, 2022-07, Vol.77, p.S62

2022

Link zum Volltext

Verfügbarkeit prüfen

Predicting post-TIPSS mortality: external validation of the FIPS score in a Canadian cohort

Journal of hepatology, 2023-06, Vol.78, p.S314

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT-548 - Predicting post-TIPSS mortality: external validation of the FIPS score in a Canadian cohort

Journal of hepatology, 2023-06, Vol.78, p.S314-S314

2023

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection

Alimentary pharmacology & therapeutics, 2010-08, Vol.32 (3), p.344-355

2010

Link zum Volltext

Verfügbarkeit prüfen

Management of severe, steroid-resistant and steroid-refractory hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

Journal of hepatology, 2022-07, Vol.77, p.S395-S396

2022

Link zum Volltext

Verfügbarkeit prüfen

Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.692-704.e9

2019

Link zum Volltext

Verfügbarkeit prüfen

PS-139-Liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

Journal of hepatology, 2019-04, Vol.70 (1), p.e89-e89

2019

Link zum Volltext

Verfügbarkeit prüfen

50th International Liver Congress: update on viral hepatitis: 22–26 April 2015, Vienna, Austria

Journal of virus eradication, 2015-07, Vol.1 (3), p.227-227

2015

Link zum Volltext

Verfügbarkeit prüfen

PS-128-Risk of gall bladder cancer in patients with primary sclerosing cholangitis and gall bladder polyps: an opportunity to revisit the guidelines

Journal of hepatology, 2019-04, Vol.70 (1), p.e79-e79

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps

Liver international, 2020-02, Vol.40 (2), p.382-392

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of Severe, Steroid-Resistant and Steroid-Refractory Hepatotoxicity in Patients Treated with Checkpoint Inhibitor Immunotherapy

European medical journal. Hepatology, 2022-08, p.34-36

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection

Therapeutic Advances in Gastroenterology, 2012-03, Vol.5 (2), p.139-151

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of endothelin on submandibular salivary responses to parasympathetic stimulation in anaesthetized sheep

Autonomic neuroscience, 2002-07, Vol.99 (1), p.47-53

2002

Link zum Volltext

Verfügbarkeit prüfen

Developing New Models to Predict Treatment Outcome in Patients with Chronic Hepatitis C Infection

Cunningham, Morven Elizabeth

2016

Link zum Volltext
ProQuest

The emerging role of screen based simulators in the training and assessment of colonoscopists

Frontline Gastroenterology, 2010-07, Vol.1 (2), p.76-81

2010

Link zum Volltext

Verfügbarkeit prüfen

What to do about Hepatitis B and Hepatitis C in Patients with IBD

Clinical Dilemmas in Inflammatory Bowel Disease, 2011, p.23-26

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Challenges in Management of Immune Checkpoint Inhibitor-Associated Hepatitis

Editorial: Corticosteroids for severe checkpoint inhibitor‐induced liver injury—Not one size fits all?

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension

Development and validation of a “capture‐fusion” model to study drug sensitivity of patient‐derived hepatitis C

Checkpoint inhibitor hepatotoxicity: pathogenesis and management

Second generation direct antivirals and the way to interferon-free regimens in chronic HCV

Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity

Primary care nursing and liver management: a qualitative study from a telemedicine education program

North American evaluation of 2519 patients with primary sclerosing cholangitis: longitudinal patterns of disease activity identify and validate stable and progressive phenotypes

Predicting post-TIPSS mortality: external validation of the FIPS score in a Canadian cohort

SAT-548 - Predicting post-TIPSS mortality: external validation of the FIPS score in a Canadian cohort

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection

Management of severe, steroid-resistant and steroid-refractory hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir

PS-139-Liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

50th International Liver Congress: update on viral hepatitis: 22–26 April 2015, Vienna, Austria

PS-128-Risk of gall bladder cancer in patients with primary sclerosing cholangitis and gall bladder polyps: an opportunity to revisit the guidelines

Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps

Management of Severe, Steroid-Resistant and Steroid-Refractory Hepatotoxicity in Patients Treated with Checkpoint Inhibitor Immunotherapy

Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection

Effects of endothelin on submandibular salivary responses to parasympathetic stimulation in anaesthetized sheep

Developing New Models to Predict Treatment Outcome in Patients with Chronic Hepatitis C Infection

The emerging role of screen based simulators in the training and assessment of colonoscopists

What to do about Hepatitis B and Hepatitis C in Patients with IBD

Suchergebnisse filtern